AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · IEX Real-Time Price · USD
19.83
-1.64 (-7.64%)
Apr 18, 2024, 4:00 PM EDT - Market closed
AnaptysBio Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 46.22, with a low estimate of 21 and a high estimate of 80. The average target predicts an increase of 133.08% from the current stock price of 19.83.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 1 | 2 | 4 |
| Hold | 4 | 4 | 4 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 7 | 7 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $47 | Buy | Initiates | $47 | +137.01% | Apr 16, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $56 | Buy | Initiates | $56 | +182.40% | Apr 11, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $30 → $28 | Hold | Maintains | $30 → $28 | +41.20% | Apr 1, 2024 |
| Wedbush | Wedbush | Hold → Buy Upgrades $20 → $34 | Hold → Buy | Upgrades | $20 → $34 | +71.46% | Mar 12, 2024 |
| BTIG | BTIG | Strong Buy Initiates $55 | Strong Buy | Initiates | $55 | +177.36% | Feb 26, 2024 |
Financial Forecast
Revenue This Year
15.65M
from 17.16M
Decreased by -8.78%
Revenue Next Year
20.04M
from 15.65M
Increased by 28.03%
EPS This Year
-6.44
from -6.08
EPS Next Year
-6.11
from -6.44
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 39.8M | 56.7M | 46.6M | 105.4M | 125.2M |
| Avg | 15.7M | 20.0M | 12.7M | 36.1M | 67.7M |
| Low | n/a | n/a | n/a | 320,460 | 18.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 131.9% | 262.3% | 132.7% | 728.4% | 246.5% |
| Avg | -8.8% | 28.0% | -36.5% | 183.8% | 87.6% |
| Low | - | - | - | -97.5% | -47.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -6.12 | -4.67 | -5.65 |
| Avg | -6.44 | -6.11 | -7.05 |
| Low | -6.81 | -7.35 | -7.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.